Treatment of primary immune‐mediated hemolytic anemia with mycophenolate mofetil in two cats
- 11 January 2011
- journal article
- case report
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 21 (1) , 45-49
Abstract
Objective –To describe the use of oral mycophenolate mofetil (MMF) as an adjunctive therapy in 2 cats with primary immune‐mediated hemolytic anemia.Case Series Summary –Two cats suffering from presumptive primary immune mediated hemolytic were treated with MMF as part of their treatment regimens. Both cats had improved complete blood counts following therapy.New or Unique Information Provided –This is the first reported use of oral MMF as adjunctive treatment for cats with immune‐mediated hemolytic anemia. Outcome was favorable in both cats and no adverse effects were noted from the MMF.Keywords
This publication has 14 references indexed in Scilit:
- Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999–2008)Journal of the American Veterinary Medical Association, 2010
- Use of mycophenolate mofetil as a rescue agent in the treatment of severe generalized myasthenia gravis in three dogsJournal of Veterinary Emergency and Critical Care, 2009
- Recovery of a dog from aplastic anaemia after treatment with mycophenolate mofetilAustralian Veterinary Journal, 2007
- Immune Hemolytic Anemia—Selected TopicsHematology-American Society Hematology Education Program, 2006
- Mechanisms of Action of Mycophenolate Mofetil in Preventing Acute and Chronic Allograft RejectionTransplantation, 2005
- Treatment of Autoimmune Hemolytic AnemiaSeminars in Hematology, 2005
- Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpuraBritish Journal of Haematology, 2002
- Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989–1999)Journal of the American Veterinary Medical Association, 2001
- PHARMACODYNAMIC ASSESSMENT OF MYCOPHENOLIC ACID-INDUCED IMMUNOSUPPRESSION BY MEASUREMENT OF INOSINE MONOPHOSPHATE DEHYDROGENASE ACTIVITY IN A CANINE MODELTransplantation, 1996
- Immune-Mediated Disorders of CatsVeterinary Clinics of North America: Small Animal Practice, 1984